Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1987 1
1989 2
1990 2
1991 2
1992 5
1994 3
1995 2
1996 3
1997 2
1998 1
1999 6
2000 4
2001 5
2002 5
2003 6
2004 6
2005 9
2006 11
2007 17
2008 19
2009 16
2010 24
2011 17
2012 32
2013 28
2014 54
2015 82
2016 88
2017 92
2018 114
2019 119
2020 129
2021 147
2022 150
2023 161
2024 90

Text availability

Article attribute

Article type

Publication date

Search Results

1,243 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.
Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, Jin F, Shi M, Chen YP, Hu WH, Cheng ZB, Wang SY, Tian Y, Wang XC, Sun Y, Li JG, Li WF, Li YH, Tang LL, Mao YP, Zhou GQ, Sun R, Liu X, Guo R, Long GX, Liang SQ, Li L, Huang J, Long JH, Zang J, Liu QD, Zou L, Su QF, Zheng BM, Xiao Y, Guo Y, Han F, Mo HY, Lv JW, Du XJ, Xu C, Liu N, Li YQ, Chua MLK, Xie FY, Sun Y, Ma J. Zhang Y, et al. N Engl J Med. 2019 Sep 19;381(12):1124-1135. doi: 10.1056/NEJMoa1905287. Epub 2019 May 31. N Engl J Med. 2019. PMID: 31150573 Clinical Trial.
The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy.
Liu J, Li W, Deng KQ, Tian S, Liu H, Shi H, Fang Q, Liu Z, Chen Z, Tian T, Gan S, Hu F, Hu M, Cheng X, Ji YX, Zhang P, She ZG, Zhang XJ, Chen S, Cai J, Li H. Liu J, et al. Circ Res. 2022 May 13;130(10):1586-1600. doi: 10.1161/CIRCRESAHA.121.318866. Epub 2022 Apr 19. Circ Res. 2022. PMID: 35437018 Free article.
Asymptomatic hyperuricaemia in chronic kidney disease: mechanisms and clinical implications.
Anders HJ, Li Q, Steiger S. Anders HJ, et al. Clin Kidney J. 2023 Jan 10;16(6):928-938. doi: 10.1093/ckj/sfad006. eCollection 2023 Jun. Clin Kidney J. 2023. PMID: 37261000 Free PMC article. Review.
Asymptomatic hyperuricaemia (HU) is considered a pathogenic factor in multiple disease contexts, but a causative role is only proven for the crystalline form of uric acid in gouty arthritis and urate nephropathy. ...In addition, we address potential therapeutic approaches …
Asymptomatic hyperuricaemia (HU) is considered a pathogenic factor in multiple disease contexts, but a causative role is only proven …
Erratum to: Huang X-D, Li Y-C, Chen F-P, Zheng W-H, Zhou G-Q, Lin L, Hu J, He W-J, Zhang L-L, Kou J, Ma J, Zhang W-D, Qi Z-Y, and Sun Y. Evolution and Dosimetric Analysis of Magnetic Resonance Imaging-Detected Brain Stem Injury After Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2019;105:124-131.
[No authors listed] [No authors listed] Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):651. doi: 10.1016/j.ijrobp.2019.12.001. Int J Radiat Oncol Biol Phys. 2020. PMID: 32014155 No abstract available.
Re: Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach: J. D. Sammon, P. I. Karakiewicz, M. Sun, S. Sukumar, P. Ravi, K. R. Ghani, M. Bianchi, J. O. Peabody, S. F. Shariat, P. Perrotte, J. C. Hu, M. Menon and Q. D. Trinh J Urol 2013; 189: 1289-1294.
Froehner M, Wirth MP. Froehner M, et al. J Urol. 2013 Oct;190(4):1440-1. doi: 10.1016/j.juro.2013.04.133. Epub 2013 Jul 22. J Urol. 2013. PMID: 23886883 No abstract available.
Erratum for the Research Article: "Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance" by W. Roh, P.-L. Chen, A. Reuben, C. N. Spencer, P. A. Prieto, J. P. Miller, V. Gopalakrishnan, F. Wang, Z. A. Cooper, S. M. Reddy, C. Gumbs, L. Little, Q. Chang, W.-S.Chen, K. Wani, M. P. De Macedo, E. Chen, J. L. Austin-Breneman, H. Jiang, J. Roszik, M. T. Tetzlaff, M. A. Davies, J. E. Gershenwald, H. Tawbi, A. J. Lazar, P. Hwu, W.-J. Hwu, A. Diab, I. C. Glitza, S. P. Patel, S. E. Woodman, R. N. Amaria, V. G. Prieto, J. Hu, P. Sharma, J. P. Allison, L. Chin, J. Zhang, J. A. Wargo, P. A. Futreal.
[No authors listed] [No authors listed] Sci Transl Med. 2017 Apr 12;9(385):eaan3788. doi: 10.1126/scitranslmed.aan3788. Sci Transl Med. 2017. PMID: 28404861 No abstract available.
The Frailty Index and colon cancer: a 2-sample Mendelian-randomization study.
Gao L, Di X, Gao L, Liu Z, Hu F. Gao L, et al. J Gastrointest Oncol. 2023 Apr 29;14(2):798-805. doi: 10.21037/jgo-23-134. J Gastrointest Oncol. 2023. PMID: 37201057 Free PMC article.
To estimate the causal effect of the Frailty Index on colon cancer, the MR-Egger regression, weighted median (WM1), inverse-variance weighted (IVW), and weight mode (WM2) methods were applied to calculate the SNP-frailty index and the SNP-cancer estimates. Cochran's Q stat …
To estimate the causal effect of the Frailty Index on colon cancer, the MR-Egger regression, weighted median (WM1), inverse-variance weighte …
1,243 results